Free Review Articles on Niacin                                 Metatextbook

Freie Reviews über Niacin                                 Look here for Journal Homepages

  • Lipoprotein a
  • Niacin
  • Laropiprant
  • HDL
  • Prostaglandin D2
  • GPR109A HM74A
  • Ezetimibe
  • Lipoprotein (Dyslipoproteinemia Hyperlipoproteinemia)
  • Statin
  • Torcetrapib
  • Colesevelam
  • Avasimibe
  • Fibrate
  • Implitapide
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12004New perspectives on the use of niacin in the treatment of lipid disorders.



    		+-nlArch Intern Med 164(7):697-705 (2004)
    22009Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin.



    		+-nlVasc Health Risk Manag 5(1):31-43 (2009)
    32008Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatin.



    		+-nlVasc Health Risk Manag 4(5):1001-9 (2008)
    42010Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.



    		+-nlTher Clin Risk Manag 6(-):183-90 (2010)
    52002Understanding niacin formulations.



    		+-nlAm J Manag Care 8(12 Suppl):S308-14 (2002)
    62002Niacin-based therapy for dyslipidemia: past evidence and future advances.



    		+-nlAm J Manag Care 8(12 Suppl):S315-22 (2002)
    72003Niacin as a component of combination therapy for dyslipidemia.



    		+-nlMayo Clin Proc 78(6):735-42 (2003)
    82008Of mice and men: blowing away the cobwebs from the mechanism of action of niacin on HDL metabolism.



    		+-nlArterioscler Thromb Vasc Biol 28(11):1892-5 (2008) Watts GF
    92009Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.



    		+-nlBr J Pharmacol 158(2):429-41 (2009)
    102006Lipid-lowering drugs.



    		+-nlCell Mol Life Sci 63(10):1165-78 (2006)
    112011The resurgence of niacin: from nicotinic acid to niaspan/laropiprant.



    		+-nlIsr Med Assoc J 13(6):368-74 (2011)
    122009Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia.



    		+-nlVasc Health Risk Manag 5(-):901-8 (2009)
    132007Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study.



    		+-nlVasc Health Risk Manag 3(4):467-79 (2007)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.